COMMUNIQUÉS West-GlobeNewswire

VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call
23/04/2019
10mcg dose selected to advance into Part B of Phase 1/2a study of VBI-1901 in recurrent GBM Expanded data from Part A of the Phase 1/2a study of VBI-1901 selected for poster presentation at ASCO Conference call and [...]
Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call
23/04/2019
MALVERN, Pa., April 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
ChemioCare Announces Initiation of PETT Based (Permeation Enhanced Transdermal Technology) Lenalidomide Program
23/04/2019
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the Company is initiating development of [...]
Maple Leaf Green World Inc. Announces Proposed Sale of Land in Henderson, Nevada, with the Proposed Use of Proceeds for the Acquisition of a Cannabis Cultivation License in Nevada
23/04/2019
CALGARY, Alberta, April 23, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) is pleased to announce it has executed a listing agreement with Cornerstone [...]
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia
23/04/2019
LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, [...]
AzurRx BioPharma Exceeds 50% Enrollment Target for Phase II OPTION Clinical Trial
23/04/2019
Enrollment in AzurRx’s Phase II OPTION study passes 50% enrollment target Initial top line data of MS1819-SD in Cystic Fibrosis Patients expected in Summer 2019 NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AzurRx [...]
ProMIS Neurosciences to Participate in the Think Equity Investor Conference
23/04/2019
Company to showcase its innovative Alzheimer’s, Parkinson’s and ALS programs TORONTO and CAMBRIDGE, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company [...]
Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019
23/04/2019
SAN DIEGO and TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
Myriad to Present Multiple Women’s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting
23/04/2019
SALT LAKE CITY, April 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present data from several [...]
Athenex Announces Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting
23/04/2019
BUFFALO, N.Y., April 23, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
EyePoint Pharmaceuticals Announces First Quarter 2019 Financial Results Release Date and Conference Call Information
23/04/2019
WATERTOWN, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will [...]
Microbot Medical Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System
23/04/2019
HINGHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a [...]
Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse is Fully Planted; Reporting Year End Financials May 1st
23/04/2019
Pure Sunfarms on track to reach annual production run-rate of 75,000 kilograms by mid-2019 Company to host 2018 fourth quarter and year end financial results conference call Wednesday, May 1, 2019 at 8:30 a.m. ET [...]
Aleafia Health Added to NYSE-Listed AdvisorShares Pure Cannabis ETF
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) has been added to the AdvisorShares Pure Cannabis ETF (NYSE: YOLO) (“ YOLO ”), [...]
Orphazyme’s Phase II/III trial in sporadic Inclusion Body Myositis fully enrolled
23/04/2019
Orphazyme A/S Company announcement No. 13/2019 Company Registration No. 32266355 Study completion expected by end 2020 Results expected in H1 2021 Copenhagen, April 23, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a [...]
BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston
23/04/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, April 23, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem® Treatment for Acute Respiratory Distress Syndrome
23/04/2019
Off-the-shelf stem cell therapy has potential to enhance recovery for ARDS patients CLEVELAND, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its partner, HEALIOS K.K. (“ [...]
Share buy-back week 16/2019
23/04/2019
Announcement 23 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Les personnes souffrant d’obésité sont discriminées
23/04/2019
OTTAWA, 23 avr. 2019 (GLOBE NEWSWIRE) -- Le second bulletin d’Obésité Canada qui évalue l’accès au traitement conclut que les Canadiens affectés par l’obésité continuent d’être ignorés par les systèmes de santé, par les [...]

Pages